112 related articles for article (PubMed ID: 3315169)
1. Alprazolam effects in children with anxiety disorders.
Simeon JG; Ferguson HB
Can J Psychiatry; 1987 Oct; 32(7):570-4. PubMed ID: 3315169
[TBL] [Abstract][Full Text] [Related]
2. Clinical, cognitive, and neurophysiological effects of alprazolam in children and adolescents with overanxious and avoidant disorders.
Simeon JG; Ferguson HB; Knott V; Roberts N; Gauthier B; Dubois C; Wiggins D
J Am Acad Child Adolesc Psychiatry; 1992 Jan; 31(1):29-33. PubMed ID: 1537778
[TBL] [Abstract][Full Text] [Related]
3. Pregabalin for treatment of generalized anxiety disorder: a 4-week, multicenter, double-blind, placebo-controlled trial of pregabalin and alprazolam.
Rickels K; Pollack MH; Feltner DE; Lydiard RB; Zimbroff DL; Bielski RJ; Tobias K; Brock JD; Zornberg GL; Pande AC
Arch Gen Psychiatry; 2005 Sep; 62(9):1022-30. PubMed ID: 16143734
[TBL] [Abstract][Full Text] [Related]
4. A double-blind evaluation of the safety and efficacy of abecarnil, alprazolam, and placebo in outpatients with generalized anxiety disorder. Abecarnil Work Group.
Lydiard RB; Ballenger JC; Rickels K
J Clin Psychiatry; 1997; 58 Suppl 11():11-8. PubMed ID: 9363043
[TBL] [Abstract][Full Text] [Related]
5. Double-blind clinical assessment of alprazolam, a new benzodiazepine derivative, in the treatment of moderate to severe anxiety.
Greiss KC; Fogari R
J Clin Pharmacol; 1980; 20(11):693-9. PubMed ID: 6112245
[TBL] [Abstract][Full Text] [Related]
6. Alprazolam versus buspirone in the treatment of outpatients with generalized anxiety disorder.
Enkelmann R
Psychopharmacology (Berl); 1991; 105(3):428-32. PubMed ID: 1798836
[TBL] [Abstract][Full Text] [Related]
7. Alprazolam in the treatment of neurotic anxiety.
Kerry RJ; McDermott CM
Pharmatherapeutica; 1983; 3(7):451-5. PubMed ID: 6142462
[TBL] [Abstract][Full Text] [Related]
8. Alprazolam and oxazepam in the treatment of anxious out-patients with depressive symptoms: a double-blind multicenter study.
Rimón R; Kultalahti ER; Kalli A; Koskinen T; Lepola U; Naarala M; Tick E
Pharmacopsychiatry; 1991 May; 24(3):81-4. PubMed ID: 1891485
[TBL] [Abstract][Full Text] [Related]
9. Comparative studies of pharmacotherapy for school refusal.
Bernstein GA; Garfinkel BD; Borchardt CM
J Am Acad Child Adolesc Psychiatry; 1990 Sep; 29(5):773-81. PubMed ID: 2228932
[TBL] [Abstract][Full Text] [Related]
10. A double-blind study of alprazolam and oxazepam in the treatment of anxiety.
Väisänen E; Jalkanen E
Acta Psychiatr Scand; 1987 May; 75(5):536-41. PubMed ID: 3604740
[TBL] [Abstract][Full Text] [Related]
11. Bupropion effects in attention deficit and conduct disorders.
Simeon JG; Ferguson HB; Van Wyck Fleet J
Can J Psychiatry; 1986 Aug; 31(6):581-5. PubMed ID: 3093046
[TBL] [Abstract][Full Text] [Related]
12. [Efficacy and tolerance of alprazolam and bromazepam in flexible doses. Double-blind study in 119 ambulatory anxious patients].
Ropert R; Bernes J; Dachary JM
Encephale; 1987; 13(2):89-95. PubMed ID: 2885173
[TBL] [Abstract][Full Text] [Related]
13. Alprazolam withdrawal in patients with panic disorder and generalized anxiety disorder: vulnerability and effect of carbamazepine.
Klein E; Colin V; Stolk J; Lenox RH
Am J Psychiatry; 1994 Dec; 151(12):1760-6. PubMed ID: 7977882
[TBL] [Abstract][Full Text] [Related]
14. [Alprazolam in the treatment of anxiety disorders and mixed anxiety and depressive disorders. Results of multicenter clinical trial].
Kiejna A; Małyszczak K; Rzewuska M; Sobucka K; Florkowski A; Rajewski A; Rajewska J; Wojtanowska M; Dabkowski M; Brzeziński R; Rybakowski J; Sep-Kowalikowa B; Gałuszko P; Nowicki Z
Psychiatr Pol; 1996; 30(6):973-92. PubMed ID: 9132771
[TBL] [Abstract][Full Text] [Related]
15. Medication side effects in anxious patients: negative placebo responses?
Uhlenhuth EH; Alexander PE; Dempsey GM; Jones W; Coleman BS; Swiontek AM
J Affect Disord; 1998 Jan; 47(1-3):183-90. PubMed ID: 9476759
[TBL] [Abstract][Full Text] [Related]
16. Double-blind comparison of alprazolam and adinazolam for panic and phobic disorders.
Pyke RE; Greenberg HS
J Clin Psychopharmacol; 1989 Feb; 9(1):15-21. PubMed ID: 2651489
[TBL] [Abstract][Full Text] [Related]
17. Alprazolam compared to clobazam and placebo in anxious outpatients.
Castillo A; Sotillo C; Mariategui J
Neuropsychobiology; 1987; 18(4):189-94. PubMed ID: 2900483
[TBL] [Abstract][Full Text] [Related]
18. Abrupt discontinuation of alprazolam and cognitive style in patients with panic disorder: early effects on mood, performance, and vital signs.
Uhlenhuth EH; Starcevic V; Qualls C; Antal EJ; Matuzas W; Javaid JI; Barnhill J
J Clin Psychopharmacol; 2006 Oct; 26(5):519-23. PubMed ID: 16974197
[TBL] [Abstract][Full Text] [Related]
19. Differential effects of alprazolam and imipramine in generalized anxiety disorder: somatic versus psychic symptoms.
Hoehn-Saric R; McLeod DR; Zimmerli WD
J Clin Psychiatry; 1988 Aug; 49(8):293-301. PubMed ID: 3045099
[TBL] [Abstract][Full Text] [Related]
20. Concurrent use of buspirone in anxious patients during withdrawal from alprazolam therapy.
Udelman HD; Udelman DL
J Clin Psychiatry; 1990 Sep; 51 Suppl():46-50. PubMed ID: 2211568
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
